Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease
- Conditions
- Behcet SyndromeAutoimmune
- Interventions
- Radiation: Diode laser 980nm&100 mWatt
- Registration Number
- NCT03771768
- Lead Sponsor
- Cairo University
- Brief Summary
Laser therapy is increasingly showing promising results in dental field including oral ulcers.This trial will assess the usefulness of Diode Laser compared to corticosteroid on oral ulcers of patients diagnosed with Behcet's disease.
- Detailed Description
The enrolled patients will be divided randomly into two groups.one group will receive Diode Laser (power:100 milli Watt,wavelength:980 mmm, delivery system:biostimulation probe) and other group will receive topical corticosteroids(Kenacort A Orabase: triamcinolone acetonide 0.1% 5 gram adhesive paste - Dermaphor) four times daily.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 38
- patients diagnosed with Behcet's Disease according to International Criteria for BD.
- patients with active oral ulcers.
- patients free from any visible oral lesions other than the oral ulcers of BD.
- patients who agreed to take the supplied interventions.
- patients who will agree to participate in the study.
- patients who will accept to sign the informed consent.
- patients not physically able to participate in survey or clinical oral examination.
- patients with organ or life-threatening disease.
- patients with history of a severe or chronic medical condition including tuberculosis, hepatitis and human immunodeficiency virus.
- patients under immunosuppressive drugs.
- patients with organ transplantation.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Diode laser Diode laser 980nm&100 mWatt Diode laser 980 nm \& 100mWatt. Triamcinolone acetonide Triamcinolone Acetonide Triamcinolone acetonide 0.1% 5 gm adhesive paste 4 times / day for 1 month.
- Primary Outcome Measures
Name Time Method Oral ulcer activity index One month Composite index score (0-10)
- Secondary Outcome Measures
Name Time Method Pain associated with oral ulcer One month Visual analogue scale (0-10)
Oral health - related quality of life One month Oral health impact profile - 14 (OHIP- 14)